Nima Rouhani

585 total citations
6 papers, 423 citations indexed

About

Nima Rouhani is a scholar working on Infectious Diseases, Neurology and Small Animals. According to data from OpenAlex, Nima Rouhani has authored 6 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Neurology and 1 paper in Small Animals. Recurrent topics in Nima Rouhani's work include COVID-19 Clinical Research Studies (4 papers), Long-Term Effects of COVID-19 (4 papers) and Inflammasome and immune disorders (1 paper). Nima Rouhani is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), Long-Term Effects of COVID-19 (4 papers) and Inflammasome and immune disorders (1 paper). Nima Rouhani collaborates with scholars based in Iran. Nima Rouhani's co-authors include Narges Karimi, Athena Sharifi‐Razavi, Ebrahim Salehifar, Nahal Mansouri, Parissa Farnia, Majid Amiri, Narges Alipanah, Mohammad Reza Masjedi, Payam Tabarsi and Ehsan Chitsaz and has published in prestigious journals such as The American Journal of the Medical Sciences, International Immunopharmacology and Journal of Investigative Medicine.

In The Last Decade

Nima Rouhani

6 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nima Rouhani Iran 6 322 301 73 46 43 6 423
Sophie Henrard Belgium 7 208 0.6× 153 0.5× 56 0.8× 39 0.8× 40 0.9× 16 328
Élodie Brison Canada 6 279 0.9× 264 0.9× 64 0.9× 25 0.5× 26 0.6× 7 400
Tarek Aldabbagh Saudi Arabia 4 222 0.7× 241 0.8× 54 0.7× 9 0.2× 43 1.0× 7 354
Giulia Renisi Italy 7 261 0.8× 254 0.8× 65 0.9× 12 0.3× 28 0.7× 18 434
Beatriz Gómez‐Vicente Spain 5 139 0.4× 80 0.3× 55 0.8× 33 0.7× 53 1.2× 9 218
Miguel Ortiz United States 5 148 0.5× 334 1.1× 20 0.3× 29 0.6× 47 1.1× 9 479
Taotao Liu China 4 165 0.5× 160 0.5× 47 0.6× 9 0.2× 23 0.5× 10 279
L. Toko France 3 297 0.9× 252 0.8× 38 0.5× 177 3.8× 13 0.3× 6 471
José Luis Cortes-Cuevas Spain 4 183 0.6× 183 0.6× 35 0.5× 157 3.4× 24 0.6× 6 389
N.J. Kadiane-Oussou France 3 304 0.9× 251 0.8× 38 0.5× 186 4.0× 13 0.3× 8 479

Countries citing papers authored by Nima Rouhani

Since Specialization
Citations

This map shows the geographic impact of Nima Rouhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nima Rouhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nima Rouhani more than expected).

Fields of papers citing papers by Nima Rouhani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nima Rouhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nima Rouhani. The network helps show where Nima Rouhani may publish in the future.

Co-authorship network of co-authors of Nima Rouhani

This figure shows the co-authorship network connecting the top 25 collaborators of Nima Rouhani. A scholar is included among the top collaborators of Nima Rouhani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nima Rouhani. Nima Rouhani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Rouhani, Nima, et al.. (2023). The effects of colchicine on hospitalized COVID-19 patients: A randomized, double-blind, placebo-controlled clinical trial. Journal of Investigative Medicine. 71(2). 124–131. 7 indexed citations
2.
Rouhani, Nima, et al.. (2021). Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial. International Immunopharmacology. 98. 107871–107871. 41 indexed citations
3.
Rouhani, Nima, et al.. (2021). Pentoxifylline effects on hospitalized patients with COVID19: A randomized, double-blind clinical trial. International Immunopharmacology. 101(Pt B). 108227–108227. 7 indexed citations
4.
Sharifi‐Razavi, Athena, Narges Karimi, & Nima Rouhani. (2020). COVID-19 and intracerebral haemorrhage: causative or coincidental?. New Microbes and New Infections. 35. 100669–100669. 216 indexed citations
5.
Karimi, Narges, Athena Sharifi‐Razavi, & Nima Rouhani. (2020). Frequent Convulsive Seizures in an Adult Patient with COVID-19: A Case Report. Iranian Red Crescent Medical Journal. 22(3). 118 indexed citations
6.
Tabarsi, Payam, Parvaneh Baghaei, Parissa Farnia, et al.. (2009). Nontuberculous Mycobacteria Among Patients Who are Suspected for Multidrug-Resistant Tuberculosis—Need for Earlier Identification of Nontuberculosis Mycobacteria. The American Journal of the Medical Sciences. 337(3). 182–184. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026